Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.67M Sell
18,616
-2,249
-11% -$946K 6.86% 8
2026
Q1
$7.88M Buy
20,865
+1,710
+9% +$732K 6.4% 9
2025
Q4
$8.2M Sell
19,155
-1,820
-9% -$792K 7.51% 8
2025
Q3
$9.39M Buy
20,975
+5,493
+35% +$2.49M 8.55% 8
2025
Q2
$7.54M Buy
15,482
+635
+4% +$362K 7.79% 10
2025
Q1
$9.14M Buy
+14,847
New +$8.44M 10.69% 3

Other funds holding CHE

DRH Investments's CHE Position: Q2 2026 in Review

DRH Investments reduced its Chemed (CHE) stake by 11% in Q2 2026, selling an estimated $946K and leaving 18,616 shares worth $8.67M. The position accounts for 6.86% of the portfolio, ranked #8.

DRH Investments first reported a position in CHE in Q1 2025 and has held it in 6 quarters since. The position peaked at $9.39M in Q3 2025. 530 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • DRH Investments held 18,616 shares of Chemed worth $8.67M as of Q2 2026.
  • DRH Investments sold 2,249 Chemed shares in Q2 2026, an estimated $946K.
  • Chemed made up 6.86% of DRH Investments's portfolio in Q2 2026, its #8 holding.
  • DRH Investments first reported a position in Chemed in Q1 2025 and has held it in 6 quarters since.
  • DRH Investments's Chemed position peaked at $9.39M in Q3 2025.
  • 530 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on DRH Investments's 13F filing for Q2 2026, filed 14 Aug 2026.